X
Get new exclusive access to healthcare business reports & breaking news
Biotech
A United Kingdom based biotechnology company focusing on novel cancer therapies has secured $84 million in a Series ...
The clinical-stage biopharmaceutical firm Principia Biopharma, which researches and develops pharmaceutical treatments for inflammatory and autoimmune diseases, has ...
Privately owned Entasis Therapeutics, a company working on new antibacterial drugs to treat drug-resistant bacterial infections, is going ...
A new biotechnology company, Ambys Medicines, which is developing regenerative medicines for liver disease, recently raised $60 million ...
A Series C funding round by SQZ Biotech – a cell therapy firm developing new treatments for ...
The Illinois Department of Public Health (IDPH) has announced that the prevalence of hepatitis C infections in the ...
This spring, an investor-backed British artificial intelligence start-up, BenevolentAI, received $115 million to prepare an ALS drug for ...
Biotechnology has profoundly changed the way people are being diagnosed and treated. Medical trail blazers across the globe ...
Organization: Stanford University, BioCardia Interviewee: Dr. Simon H. Stertzer, Professor Emeritus Simon H. Stertzer, MD is Professor Emeritus at ...
